We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 1AI market cap is 10.63M. The company's latest EPS is AUD -0.0013 and P/E is -7.69.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 450k | 244k | 0 | 0 | 0 |
| Operating Income | -1.55M | -1.91M | -2.38M | -2.13M | -2.2M |
| Net Income | -968k | -1.46M | -1.96M | -2.11M | -2.1M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.39M | 1.64M | 4.27M | 4.21M | 3.19M |
| Total Liabilities | 513k | 265k | 239k | 450k | 179k |
| Total Equity | 2.88M | 1.38M | 4.04M | 3.76M | 3.01M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.11M | -1.46M | -2.04M | -1.99M | -1.52M |
| Investing | 1.24M | 106k | 39k | N/A | -278k |
| Financing | -50k | -45k | 4.69M | 1.85M | 523k |
| Market Cap | 10.63M |
| Price to Earnings Ratio | -7.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 20 |
| Price to Book Ratio | 5.43 |
| Dividend Yield | - |
| Shares Outstanding | 1.64B |
| Average Volume (1 week) | 442.2k |
| Average Volume (1 Month) | 595.47k |
| 52 Week Change | -35.00% |
| 52 Week High | 0.013 |
| 52 Week Low | 0.005 |
| Spread (Intraday) | 0 (14.29%) |
| Company Name | Algorae Pharmaceuticals Limited |
| Address |
level 7 melbourne, victoria 3000 |
| Website | https://www.lctglobal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
